Navigation Links
India In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture
Date:1/11/2012

Pharmaceuticals Enters Into Distribution Agreement With Super Religare Laboratories 180

Table 77: Transasia Enters Into Distribution Agreement With Gen-Probe 181

Table 78: Transasia Enters Into Distribution Agreement With InTec 182

Table 79: Transasia Enters Into Distribution Agreement Vircell Microbiologists 183

Table 80: Vermillion Signs Agreement With Quest Diagnostics 184

Table 81: Trivitron Enters Into Distribution Agreement With Celerus Diagnostics 185

Table 82: USD to Local Currency, India, Average Actual Rate 2003-2010 205

List of Figures

Figure 1: In Vitro Diagnostics, Market Segmentation 15

Figure 2: In Vitro Diagnostics, India, Overall Revenue ($m), USD Actual, 2003-2017 16

Figure 3: In Vitro Diagnostics Market, India, Revenue Mix ($m), 2010 18

Figure 4: In Vitro Diagnostics Market, India, Category Contribution (%), 2010 19

Figure 5: In Vitro Diagnostics, India, Cross-Category Analysis, 2003-2017 20

Figure 6: In Vitro Diagnostics, India, Overall Revenue ($m), USD Actual, Historic, 2003-2010 22

Figure 7: In Vitro Diagnostics, India, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 24

Figure 8: In Vitro Diagnostics, India, Company Share (%), 2010 26

Figure 9: Clinical Chemistry, Market Segmentation 28

Figure 10: Clinical Chemistry Market, India, Revenue Mix ($m), 2010 29

Figure 11: Clinical Chemistry Market, India, Segment Contribution (%), 2010 30

Figure 12: Clinical Chemistry, India, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 31

Figure 13: Clinical Chemistry, India, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 33

Figure 14: Clinical Chemisty Analyzers, India, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 35

Figure 15: Clinical Chemisty Analyzers, India, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 37

Figure 16: Urine Analysis, In
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. ThermoGenesis Announces Approval of AXP® by India Ministry of Health
2. BioStorage Technologies Mike Reffeitt Named "CFO of the Year" by Indianapolis Business Journal
3. Sweet Success for Hosmac India Pvt. Ltd. at ET NOW-IndiaMART Leaders of Tomorrow Awards 2011
4. BioCrossroads Awards Indiana Life Sciences Leaders
5. CTRI Confirms Leading Indian CRO Supports Majority of Hemophilia Trials in India
6. MU signs academic agreement with K.S.R. Educational Institutions of India
7. IndiaMART.com to Step Up B2B Matchmaking at Global Trade Events
8. Strategic Analysis of Indian Biosimilar Market
9. Bharat Renewable Energy Forms Alliance With SG Biofuels to Deploy Jatropha Hybrids for Biodiesel in India
10. Life Technologies Launches New Distribution Center in India
11. Indianas $44 Billion Life Sciences Industry Packs a Powerful Punch
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... SC (PRWEB) October 22, 2014 ... of its cardiovascular pharmacogenetics menu, which enables healthcare ... outcomes. With PCLS’s evidence-based results, healthcare providers ... and optimize their therapy, while minimizing risks for ... the U.S., according to the FDA [1] more ...
(Date:10/22/2014)... 2014   Synthetic Biologics, Inc. (NYSE MKT: ... serious infections and diseases, announced today that the U.S. ... Allowance for a composition of matter patent application that ... program, SYN-004. This is Synthetic Biologics, first allowed patent ... adds to the Company,s extensive C. difficile ...
(Date:10/22/2014)... , Oct. 22, 2014 Nuvilex, Inc. ... approximately 400 million people worldwide are living with diabetes, ... people by 2030.  The global market for diabetes treatments ... approximately 330,000 people worldwide died from pancreatic cancer.  Pancreatic ... due to cancer in the United States ...
(Date:10/22/2014)... HONG KONG , Oct. 22, 2014 ... enterprise, announced today that rare disease expert John ... president, research. Dr. McKew brings more than two decades ... at the National Institutes of Health, Wyeth Research and ... McKew will lead aTyr,s efforts to expand and translate ...
Breaking Biology Technology:PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3
... WA, May 1 /PRNewswire-FirstCall/ - Oncothyreon Inc. ... filed an investigational new,drug (IND) application with ... a small molecule phosphatidylinositol-3-kinase (PI-3-kinase),inhibitor for the ... plans to initiate a Phase 1 clinical ...
... produced tiny liquid crystal devices with electrodes made from ... computer and TV displays based on this technology. , ... Dr Kostya Novoselov and colleagues from The School of ... report on the use of graphene as a transparent ...
... SAN DIEGO, April 30 Anadys Pharmaceuticals,Inc. (Nasdaq: ... improving,patient care by developing novel medicines in the ... financial results and highlights for the first,quarter ended ... in both of our development programs,during the first ...
Cached Biology Technology:Oncothyreon files investigational new drug application for PX-866 oncology compound 2Oncothyreon files investigational new drug application for PX-866 oncology compound 3Graphene-based gadgets may be just years away 2Anadys Pharmaceuticals Reports First Quarter 2008 Financial Results and Highlights 2Anadys Pharmaceuticals Reports First Quarter 2008 Financial Results and Highlights 3Anadys Pharmaceuticals Reports First Quarter 2008 Financial Results and Highlights 4Anadys Pharmaceuticals Reports First Quarter 2008 Financial Results and Highlights 5Anadys Pharmaceuticals Reports First Quarter 2008 Financial Results and Highlights 6Anadys Pharmaceuticals Reports First Quarter 2008 Financial Results and Highlights 7Anadys Pharmaceuticals Reports First Quarter 2008 Financial Results and Highlights 8
(Date:10/17/2014)... is available in German . ... very few drugs. When treating overdoses, doctors are often limited ... difficult if there is a combination of drugs involved. So ... accidentally swallows his grandmother,s pills? ETH professor Jean-Christophe Leroux from ... find an answer to this question. "The task was to ...
(Date:10/16/2014)... are anything but sustainable: environmental damage to soil ... increasingly evident. Despite their disadvantages, however, monocultures remain ... the sole possibility of achieving higher yields in ... an ecology professor at the University of Zurich, ... forestry. After all, a new study carried out ...
(Date:10/15/2014)... assess the pandemic risk from strains of influenza virus ... allow ourselves to become complacent that the most substantial ... scientists. , Influenza pandemics arise when a new virus ... widespread immunity – spreads in the human population. There ... years, the worst of which – the 1918 Spanish ...
Breaking Biology News(10 mins):Emergency aid for overdoses 2Emergency aid for overdoses 3Plant communities produce greater yield than monocultures 2Plant communities produce greater yield than monocultures 3Scientists 'must not become complacent' when assessing pandemic threat from flu viruses 2
... Researchers at the Hebrew University of Jerusalem have discovered ... utilizing human embryonic stem cells. Their work paves the ... stem cell therapy. Human embryonic stem cells ... the mature human body (and are hence defined as ...
... people are alike." Yet when we consider the thousands of ... it is remarkable how much alike we are. ... but a general property of life. Biologists have long pondered ... great variation in genetics as well as environmental conditions. ...
... for Research Resources (NCRR), part of the National ... up to an estimated $122 million over the ... (IDeA) Networks of Biomedical Research Excellence (INBRE) in ... and sharing of research resources and expertise, these ...
Cached Biology News:Hebrew University researchers neutralize tumor growth in embryonic stem cell therapy 2Researchers find snippet of RNA that helps make individuals remarkably alike 2NIH grants $122 million in Institutional Development Awards 2NIH grants $122 million in Institutional Development Awards 3
... The powerful solution for all plate washing ... format. ,The PW 384 provides an ... field of Drug Discovery (Assay development, Screening or ... speed ,The PW 384 has set ...
... Model 1575 immunowash microplate washer, 100-240 V, ... have flat-, U-, or V-bottom wells. This ... needle positions to an accuracy of 0.1 ... overflow washing. It can store up to ...
... a compact benchtop and stackable multi-function ... with a large display screen to ... Air circulation inside to evenly distribute ... be easily calibrated from the microprocessor ...
... compact benchtop and stackable multi-function incubator. ... a large display screen to accurately ... circulation inside to evenly distribute temperature ... easily calibrated from the microprocessor controller. ...
Biology Products: